[The contribution of magnetic resonance imaging to the diagnosis of type I glutaric aciduria].
González-Granado
L I
LI
D000592:Amino Acid Metabolism, Inborn Errors / Q000150:complications*; D000927:Anticonvulsants / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002331:Carnitine / Q000172:deficiency*; D004827:Epilepsy / Q000188:drug therapy* / Q000209:etiology; D018755:GABA Agonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D050770:Glutaryl-CoA Dehydrogenase / Q000172:deficiency*; D006801:Humans; D008928:Mitochondria / Q000187:drug effects; D014635:Valproic Acid / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D020888:Vigabatrin / Q000627:therapeutic use
D000927:Anticonvulsants; D018755:GABA Agonists; D014635:Valproic Acid; D050770:Glutaryl-CoA Dehydrogenase; D020888:Vigabatrin; D002331:Carnitine